
|Articles|October 26, 2015
PRA Opens New Lab in Netherlands
Advertisement
PRA Health Sciences has opened a new, state-of-the-art Bioanalytical Laboratory in Assen, the Netherlands. The 33,000 square foot facility provides 25 percent more space than PRA’s previous lab, includes investments in the newest small and large molecule equipment, and allows for optimal bioanalytical process efficiencies. The new laboratory is also located close to PRA’s Phase I clinics in Groningen and Zuidlaren.
Read
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The CRA of the Future: From Monitoring Activity to Strategic Site Partnership
2
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
3
ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced
4
Survey Finds US Biotechs Prefer Domestic First-in-Human Trials but FDA Hurdles Are Pushing Them Abroad
5



